FDA White Oak Construction Nears Completion, But Some Plans On Hold
This article was originally published in The Tan Sheet
The biodefense complex would remain on schedule for fiscal 2014 completion, but communications and logistical buildings included in the master plan would be on hold. FDA tells Congress the sprawling campus must receive necessary operational funds as more employees move there.
You may also be interested in...
Proposed and existing user fees would fund 44% of the $4.5 billion FDA FY 2013 spending plan. User fees are projected at $20 million for biosimilars and $229 million for generic drugs.
Agency will spend more than 78% of $150.6 million fund by the end of FY 2012 to move CBER to White Oak and pay for new drug safety personnel.
President Obama's fiscal 2012 budget request concurs with FDA in recommending that Congress expand the type of user fees that industry pays for food safety enforcement reform.